Correlation Between Qualigen Therapeutics and INVO Bioscience

Can any of the company-specific risk be diversified away by investing in both Qualigen Therapeutics and INVO Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qualigen Therapeutics and INVO Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Qualigen Therapeutics and INVO Bioscience, you can compare the effects of market volatilities on Qualigen Therapeutics and INVO Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qualigen Therapeutics with a short position of INVO Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qualigen Therapeutics and INVO Bioscience.

Diversification Opportunities for Qualigen Therapeutics and INVO Bioscience

-0.3

Correlation Coefficient

Qualigen Therapeutics  INVO Bioscience

Very good diversification

The 3 months correlation between Qualigen and INVO is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Qualigen Therapeutics and INVO Bioscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INVO Bioscience and Qualigen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qualigen Therapeutics are associated (or correlated) with INVO Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INVO Bioscience has no effect on the direction of Qualigen Therapeutics i.e., Qualigen Therapeutics and INVO Bioscience go up and down completely randomly.

Pair Corralation between Qualigen Therapeutics and INVO Bioscience

Given the investment horizon of 90 days Qualigen Therapeutics is expected to under-perform the INVO Bioscience. In addition to that, Qualigen Therapeutics is 1.21 times more volatile than INVO Bioscience. It trades about -0.01 of its total potential returns per unit of risk. INVO Bioscience is currently generating about 0.03 per unit of volatility. If you would invest  77.00  in INVO Bioscience on October 8, 2024 and sell it today you would lose (5.00) from holding INVO Bioscience or give up 6.49% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	94.4%
Values	Daily Returns

Qualigen Therapeutics  vs.  INVO Bioscience

Qualigen Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Qualigen Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

INVO Bioscience

Risk-Adjusted Performance

0 of 100

Insignificant

Over the last 90 days INVO Bioscience has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very weak basic indicators, INVO Bioscience displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Qualigen Therapeutics and INVO Bioscience

The main advantage of trading using opposite Qualigen Therapeutics and INVO Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qualigen Therapeutics position performs unexpectedly, INVO Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INVO Bioscience will offset losses from the drop in INVO Bioscience's long position.

The idea behind Qualigen Therapeutics and INVO Bioscience pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.